Key result
Quercetin co-treatment alleviated doxorubicin-induced alterations in hematological variables, serum immunoglobulins, spleen antioxidant status, and pro-inflammatory responses in rats.
Why the study?
Doxorubicin has undesirable side effects including immunosuppression, prompting investigation into whether the natural antioxidant flavonoid quercetin could alleviate these hematological and immunological dysfunctions.
Does Quercetin alleviate Doxorubicin-induced hematological and immunological dysfunctions in rats?
Does Quercetin alleviate Doxorubicin-induced hematological and immunological dysfunctions in rats?
Quercetin supplementation may protect against doxorubicin-induced immunotoxicity and oxidative stress in a rat model.
Quercetin merits further rodent validation for DOX toxicities; leaves open human translation in oncology.
Doxorubicin (DOX) is a chemotherapeutic agent against hematogenous and solid tumors with undesirable side effects including immunosuppression. Quercetin (QUR), a natural flavonoid abundant in fruits and vegetables, has a potent antioxidant activity. The aim of the current study was to assess the impact of QUR on DOX-induced hematological and immunological dysfunctions in a rodent model. Randomly grouped rats were treated as follows: control, QUR alone (50 mg/kg for 15 days per os), DOX alone (2.5 mg/kg I/P, three times a week, for two weeks), and co-treated rats with QUR for 15 days prior to and concomitantly with DOX (for two weeks), at the doses intended for groups two and three. DOX alone significantly disrupted the erythrogram and leukogram variables. Serum immunoglobulin (IgG, IgM, and IgE) levels and the activities of catalase (CAT) and superoxide dismutase (SOD) in spleen were declined. The DNA damage traits in spleen were elevated with an upregulation of the expression of the apoptotic markers (p53 and Caspase-3 genes) and the proinflammatory cytokines (IL-6 and TNF-α genes), while the expression of CAT gene was downregulated. These biochemical changes were accompanied by morphological changes in the spleen of DOX-treated rats. Co-treatment with QUR abated most of the DOX-mediated alterations in hematological variables, serum immunoglobulins, and spleen antioxidant status, pro-inflammatory and apoptotic responses, and histopathological alterations. In essence, these data suggest that QUR alleviated DOX-induced toxicities on the bone marrow, spleen, and antibody-producing cells. Supplementation of chemotherapy patients with QUR could circumvent the DOX-induced inflammation and immunotoxicity, and thus prevent chemotherapy failure.
No takes yet. Share an insight, caveat, or question.
Farag et al. (2021) studied Doxorubicin-induced hematological and immunological dysfunctions. Quercetin vs. Doxorubicin alone, Quercetin alone, and untreated control was evaluated on Hematological variables, serum immunoglobulins, and spleen antioxidant status. Quercetin co-treatment alleviated doxorubicin-induced alterations in hematological variables, serum immunoglobulins, spleen antioxidant status, and pro-inflammatory responses in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: